A rapid method to isolate platelets from human blood by density gradient centrifugation.
about
The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contentsAbnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV.Low intensity laser therapy speeds wound healing in hemophilia by enhancing platelet procoagulant activity.Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin.Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stabilityA high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages.Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE(-/-) Mice Induced by HyperlipaemiaManipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia.Kinetic analysis and binding studies of a new recombinant human factor VIIa for treatment of haemophilia.Platelet binding and activity of a factor VIIa variant with enhanced tissue factor independent activity.A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.High dose factor VIIa improves clot structure and stability in a model of haemophilia B.A rationally designed heparin, M118, has anticoagulant activity similar to unfractionated heparin and different from Lovenox in a cell-based model of thrombin generation.Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system.Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels.
P2860
Q33364277-64F52B24-E733-497F-A133-BE4DD504BC44Q33479306-485BDF8C-B01B-40A2-8772-99F11D8B151DQ34375477-314963A9-151B-42C1-83E4-EB5E8B117BF8Q36717080-79A6DDB8-46BF-4703-81EE-3CA47EE1CBFDQ37426582-4B9E4EF7-DB9B-4507-B290-700D49ECEAFDQ37450566-462E61F2-479D-418F-9BF2-F1A3E6CF73DAQ38327215-A4C25599-8D2B-44B9-AD2E-DC1459081523Q39740926-855B630A-FDF3-4CC5-A49F-BE2F4C6254A9Q41444735-7E746048-D5FF-4EB0-BF7D-C46CEA7D864AQ45859169-6742FD13-7E58-4EA0-8BE8-6428A05B4F0EQ45863062-A0C71653-9E42-451A-A559-F04211D264B5Q45866827-430E09DC-3A8B-4BD9-B504-4DDF140AE1F2Q45868696-73980060-9A35-474B-8C44-3BE5B55E9E47Q45889198-2F3B4DCD-0809-46E8-AC59-8FED188CDEA8Q45959804-650CEF33-F643-4B36-8670-33389A50A900Q47979978-8A8DAE28-7F51-4E91-8A35-45B76AE5DAC8Q51071834-15428593-8219-46B6-B00A-D20E30A773FC
P2860
A rapid method to isolate platelets from human blood by density gradient centrifugation.
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
A rapid method to isolate platelets from human blood by density gradient centrifugation.
@ast
A rapid method to isolate platelets from human blood by density gradient centrifugation.
@en
type
label
A rapid method to isolate platelets from human blood by density gradient centrifugation.
@ast
A rapid method to isolate platelets from human blood by density gradient centrifugation.
@en
prefLabel
A rapid method to isolate platelets from human blood by density gradient centrifugation.
@ast
A rapid method to isolate platelets from human blood by density gradient centrifugation.
@en
P2093
P356
P1476
A rapid method to isolate platelets from human blood by density gradient centrifugation.
@en
P2093
P304
P356
10.1093/AJCP/98.5.531
P407
P577
1992-11-01T00:00:00Z